Whitepaper: Lipid-based nanoparticles: Manufacturing and inline size characterisation
Supported by:
Published: 30 May 2023
Share this post
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
Lipid-based Nano Particles form a very useful class of delivery systems in the pharmaceutical area as well as in cosmetics (and food/nutraceuticals).
The recently developed LNP formulations for COVID-19 vaccines highlight this prominent role of Lb-NPs. With the often-complex manufacturing methods of the nano-formulations and the strict size specifications to achieve optimal performance-particularly for nanomedicines-, inline characterization and PAT for nano-suspension manufacturing process has become increasingly important.
The NanoFlowSizer: An unmatched technology for nanoparticle size analysis
- Continuous size characterisation of nanoparticles during processing in flow
- Inline Process Analytical Tool
- Non-invasive measurement
- Real-time process feedback and control
- Measurement of highly turbidity suspensions and dispersions
Learn why the top mRNA LNP vaccine companies have chosen the NanoFlowSizer as their instrument for measuring quality of their vaccines.
Read this whitepaper about “Lipid-Based Nanoparticles: Manufacturing and inline size Characterization” to further discover the unique capabilities of the NanoFlowSizer.
